Syngene - Jonathan Hunt
Syngene International Limited, a pharma research and manufacturing firm spunout from India’s Biocon has named Jonathan Hunt as CEO-designate, replacing Peter Bains who is retiring in March.
“Syngene, with its differentiated strategy of multi model integrated Discovery, Development and Manufacturing capabilities, its expanding customer base and seasoned management team, is on a strong growth trajectory and very well positioned to continue this momentum,” said the departing CEO.
“Jonathan’s experience in building customer-focused organisations, coupled with his leadership and operational track record, make him the ideal selection for this position and we are delighted to welcome him aboard.”
